| References |
|
|
Asakai R,
Chung DW,
Ratnoff OD et al.
(1989)
Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.
Proceedings of the National Academy of Sciences of the USA
86:
7667–7671.
|
|
|
Behar DM,
Hammer MF,
Garrigan D et al.
(2004)
MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population.
European Journal of Human Genetics
12:
355–364.
|
|
|
book
Bonnè-Tamir B,
Ashbel S and
Kennet R
(1979)
"Genetic markers: benign and normal traits of Ashkenazi Jews". In:
Goodman RM and
Motulsky AG (eds)
Genetic Diseases among Ashkenazi Jews,
pp. 54–76.
New York: Raven Press.
|
|
|
Bressman SB,
de Leon D,
Brin MF et al.
(1989)
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance.
Annals of Neurology
26:
612–620.
|
|
|
Bressman SB,
de Leon D,
Kramer PL et al.
(1994)
Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation.
Annals of Neurology
36:
771–777.
|
|
|
Bruchim Bar-Sade R,
Kruglikova A,
Modan B et al.
(1998)
The 185delAG mutation originated before the dispersion of the Jews in the Diaspora and is not limited to Ashkenazim.
Human Molecular Genetics
7:
801–805.
|
|
|
Colombo R
(2000)
Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: a reappraisal of haplotype data.
American Journal of Human Genetics
66:
692–697.
|
|
|
Diaz GA,
Monfort M,
Cormand B et al.
(1999)
Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago.
American Journal of Human Genetics
64:
1233–1238.
|
|
|
Feder J,
Ovadia O,
Glaser B et al.
(2007)
Ashkenazi Jewish mtDNA haplogroup distribution varies among distinct subpopulations: lessons of population substructure in a closed group.
European Journal of Human Genetics
15:
498–500.
|
|
|
Fitzgerald MG,
MacDonald DJ,
Krainer M et al.
(1996)
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer.
New England Journal of Medicine
334:
143–149.
|
|
|
Frisch A,
Colombo R,
Michaelovsky E et al.
(2004)
Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
Human Genetics
114:
366–376.
|
|
|
book
Goodman RM
(1979)
Genetic Disorders among the Jewish People.
Baltimore, MD: Johns Hopkins University Press.
|
|
|
book
Grabowski GA
(1993)
"Gaucher disease: enzymology, genetics and treatment". In:
Harris H and
Hirschhorn K (eds)
Advances in Human Genetics,
pp. 377–441.
New York: Plenum Press.
|
|
|
Kato A,
Asakai R,
Davie EW et al.
(1989)
Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4.
Cytogenetics and Cell Genetics
52:
77–78.
|
|
|
Neill BL,
Long JC,
Rennert G and
Gruber SB
(2003)
Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.
American Journal of Human Genetics
73:
1250–1260.
|
|
|
Nemeth AH
(2002)
The genetics of primary dystonias and related disorders.
Brain
125:
695–721.
|
|
|
Neuhausen S,
Gilewski LN,
Tran T et al.
(1996)
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Nature Genetics
13:
126–128.
|
|
|
Peretz H,
Mulai A,
Usher S et al.
(1997)
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
Blood
90(7):
2654–2659.
|
|
|
Peretz H,
Zivelin A,
Usher S et al.
(1996)
A 14bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency.
Human Mutation
8:
77–78.
|
|
|
Risch N
(2001)
Molecular epidemiology of Tay-Sachs disease.
Advances in Genetics
44:
233–252.
|
|
|
Risch N,
de Leon D,
Ozelius L et al.
(1995)
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.
Nature Genetics
9:
152–159.
|
|
|
Risch N,
Tang H,
Katzenstein H and
Ekstein J
(2003)
Geographical distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.
American Journal of Human Genetics
72:
812–822.
|
|
|
book
Sachar AL
(1965)
A History of the Jews,
5th edn.
New York: A.A. Knof.
|
|
|
book
Seligsohn U
(1979)
"Factor XI (PTA) deficiency". In:
Goodman RE and
Motulsky AG (eds)
Genetic Diseases among Ashkenazi Jews,
pp. 141–148.
New York: Raven Press.
|
|
|
Shpilberg O,
Peretz H,
Zivelin A et al.
(1995)
One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews who represent the ancient gene pool of Jews.
Blood
85:
429–432.
|
|
|
Theophilus BDM,
Latham T,
Grabowski GA and
Smith FI
(1989)
Gaucher disease: molecular heterogeneity and phenotype–genotype correlations.
American Journal of Human Genetics
45:
212–215.
|
|
|
Thomas MG,
Weale ME,
Jones AL et al.
(2002)
Founding mothers of Jewish communities: geographically separated Jewish groups were independently founded by very few female ancestors.
American Journal of Human Genetics
70(6):
1411–1420.
|
|
|
Zlotogora J and
Bach Gideon
(2003)
The possibility of a selection process in the Ashkenazi Jewish population.
American Journal of Human Genetics
73:
438–440.
|
|
|
Zlotogora J and
Leventhal A
(2000)
Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
Israel Medical Association Journal
2(9):
665–667.
|
| Further Reading |
|
|
book
Bonnè-Tamir B and
Adam A (eds)
(1992)
Genetic Diversity among the Jews. Diseases and Markers at the DNA Level.
New York: Oxford University Press.
|
|
|
Charrow J
(2004)
Ashkenazi Jewish genetic disorders.
Familial Cancer
3:
201–206.
|
|
|
Ekstein J and
Katzenstein H
(2001)
The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease.
Advances in Genetics
44:
297–310.
|
|
|
book
Goodman RM and
Motulsky AG (eds)
(1979)
Genetic Diseases among Ashkenazi Jews.
New York: Raven Press.
|
|
|
Kedar-Barnes I and
Rozen P
(2004)
The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility.
Familial Cancer
3:
193–199.
|
|
|
Nebel A,
Filon D,
Brinkmann B et al.
(2001)
The Y chromosome pool of Jews as part of the genetic landscape in the Middle East.
American Journal of Human Genetics
69:
1095–1112.
|
|
|
Zhang B,
Dearing L and
Amos J
(2004)
DNA-based carrier screening in the Ashkenazi Jewish population.
Expert Review of Molecular Diagnostics
4(3):
377–392.
|
